Financials

Discussions Forecast Seasonals

A3EHWQ fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. It focuses on innovative technology platforms such as novel adjuvant, protein engineering, and immunological evaluation platforms. The company was founded by Yong Liu on May 18, 2012 and is headquartered in Taizhou City, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

A3EHWQ does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company